Cetera Investment Advisers Has $3.17 Million Stock Holdings in VanEck Pharmaceutical ETF $PPH

Cetera Investment Advisers lifted its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 4.0% during the second quarter, HoldingsChannel reports. The firm owned 36,017 shares of the company’s stock after buying an additional 1,387 shares during the quarter. Cetera Investment Advisers’ holdings in VanEck Pharmaceutical ETF were worth $3,168,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Royal Bank of Canada lifted its stake in VanEck Pharmaceutical ETF by 53.3% in the first quarter. Royal Bank of Canada now owns 67,596 shares of the company’s stock valued at $6,160,000 after buying an additional 23,491 shares in the last quarter. Adamsbrown Wealth Consultants LLC boosted its position in VanEck Pharmaceutical ETF by 12.0% during the second quarter. Adamsbrown Wealth Consultants LLC now owns 195,976 shares of the company’s stock valued at $17,238,000 after purchasing an additional 21,074 shares during the last quarter. Hudock Inc. bought a new position in shares of VanEck Pharmaceutical ETF in the second quarter valued at $811,000. Arkadios Wealth Advisors bought a new position in shares of VanEck Pharmaceutical ETF in the 2nd quarter valued at about $684,000. Finally, Phoenix Financial Ltd. grew its holdings in VanEck Pharmaceutical ETF by 13.8% during the second quarter. Phoenix Financial Ltd. now owns 61,276 shares of the company’s stock worth $5,390,000 after purchasing an additional 7,417 shares during the period.

VanEck Pharmaceutical ETF Trading Down 0.0%

PPH stock opened at $103.16 on Thursday. VanEck Pharmaceutical ETF has a 1-year low of $77.67 and a 1-year high of $103.56. The firm has a market capitalization of $1.28 billion, a PE ratio of 20.21 and a beta of 0.54. The business’s 50 day simple moving average is $93.67 and its 200 day simple moving average is $89.72.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, October 6th. Investors of record on Wednesday, October 1st were paid a $0.3931 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $1.57 dividend on an annualized basis and a yield of 1.5%.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.